Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX4XDU
|
||||
Drug Name |
2',3',4'-trifluoro-biphenyl-2-yloxy-acetaldehyde
|
||||
Synonyms |
CHEMBL387619
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C14H9F3O2
|
||||
Canonical SMILES |
Fc1ccc(c(F)c1F)c2ccccc2OCC=O
|
||||
InChI |
InChI=1S/C14H9F3O2/c15-11-6-5-10(13(16)14(11)17)9-3-1-2-4-12(9)19-8-7-18/h1-7H,8H2
|
||||
InChIKey |
SHBOZVYTDQJORM-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.